MAOI or to a combination of TCA and MAOI in the treatment of intractable Role of bupropion in the treatment of resistant depression. Management of
Concomitant use of MAOIs and bupropion is contraindicated because there is an increased risk of hypertensive reactions if bupropion is used concomitantly with MAOIs. Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine.
and bupropion initiation1. For reversible MAOIs (e.g. moclobemide) allow 24 hours between. MAOI discontinuation and bupropion initiation1.
Concomitant use of MAOIs and bupropion is contraindicated because there is an increased risk of hypertensive reactions if bupropion is used concomitantly with MAOIs. Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine.
MAOI within the next 14 days when starting bupropion. This is because an MAOI can interact with bupropion and cause your blood pressure to
At least 14 days must elapse between discontinuing an MAOI and initiating dextromethorphan/bupropion bupropion before starting an MAOI antidepressant
Concomitant use of MAOIs and bupropion is contraindicated because there is an increased risk of hypertensive reactions if bupropion is used concomitantly with MAOIs. Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine.
an MAOI intended to treat psychiatric disorders. In addition MAOIs and bupropion is contraindicated because there is an increased risk of hypertensive.
Bupropion hydrochloride 450 mg daily is equivalent to bupropion hydrobromide 522 mg once daily. MAOI recommendations: Switching to or from an MAOI
Comments